Suchergebnisse - "Boku, Narikazu"

PubPharm (910)

1

Switching from FOLFIRI plus cetuximab to FOLFIRI plus bevacizumab based on early tumor shrinkage in RAS wild-type metastatic colorectal cancer : A phase II trial (HYBRID)

enthalten in: Cancer medicine | 2024

von Arai, H. | Tsuda, T. | Sunakawa, Y. | +13

2

Multi-institutional observational study evaluating the efficacy of anti-epidermal growth factor antibody re- challenge in RAS/BRAF wild-type metastatic colorectal cancer

enthalten in: ResearchSquare.com | 2024

von Fukuda, K. | Osumi, H. | Yoshinami, Y. | +17

3

Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis : Japan Clinical Oncology Group study JCOG1301C (Trigger Study)

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Tokunaga, M. | Machida, N. | Mizusawa, J. | +12

4

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer : WJOG 11018G

enthalten in: Targeted oncology | 2024

von Matsumoto, T. | Yamamoto, Y. | Kotaka, M. | +19

5

Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704)

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Kurokawa, Y. | Doki, Y. | Kitabayashi, R. | +11

6

Risk factors for abdominal surgical infectious complications after distal gastrectomy for gastric cancer : A post-hoc analysis of a randomized controlled trial (JCOG0912)

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2024

von Taki, Y. | Ito, S. | Mizusawa, J. | +13

7

A Phase II Study of FOLFIRI Plus Ziv-Aflibercept After Trifluridine/Tipiracil Plus Bevacizumab in Patients with Metastatic Colorectal Cancer: WJOG 11018G

enthalten in: Targeted oncology | 2024

von Matsumoto, T. | Yamamoto, Y. | Kotaka, M. | +19

8

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study) : an international, randomized, placebo-controlled, phase 3 trial

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2024

von Kang, Y. | Ryu, M. | Di Bartolomeo, M. | +15

9

Protocol digest of a randomized controlled adaptive Phase II/III trial of neoadjuvant chemotherapy for Japanese patients with oesophagogastric junction adenocarcinoma : Japan Clinical Oncology Group Study JCOG2203 (NEO-JPEG)

enthalten in: Japanese journal of clinical oncology | 2024

von Kita, R. | Yanagimoto, Y. | Imazeki, H. | +13

10

Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial

enthalten in: Gastric Cancer | 2024

von Kang, Y. | Ryu, M. | Di Bartolomeo, M. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[91]